Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis

20250 citationsJournal Articlegold Open Access

Authors

Matthias Augustin · Universität Hamburg

April W. Armstrong · University of California, Los Angeles

Naiem T. Issa · University of Miami

A Petersen · Leo Pharma (Denmark)

Rie von Eyben · Leo Pharma (Denmark)

Teodora Festini · Leo Pharma (Denmark)

Tiago Torres ·

Abstract

Comparable maintenance of efficacy was observed between tralokinumab and lebrikizumab after 52 weeks of treatment among patients meeting response criteria at week 16.

Topics & Keywords

Dermatology and Skin Diseases Urticaria and Related Conditions Food Allergy and Anaphylaxis Research

Publication Details

Published in: Dermatology and Therapy

Volume 16, Issue 1, pp. 277-291

DOI: 10.1007/s13555-025-01563-3

Field-Weighted Citation Impact: 0.00

Command Palette

Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis

Authors

Abstract

Topics & Keywords

Publication Details